Michael Makris: Lower Bleeding Risk With Apixaban vs Rivaroxaban in Acute Venous Thrombosis
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared a post on LinkedIn about a recent article by Lana Castellucci et al, adding:
“Important paper for clinical practice.
A large study, independent of the pharma industry, found that in the setting of acute venous thrombosis, the risk of clinically relevant bleeding was:
- 3.3 percent with Apixaban
- 7.3 percent with Rivaroxaban
This difference was significant.
Congratulations to Lana Castellucci for coordinating this multicentre study.
We await the results of their AF study with interest.
Considering how many patients worldwide are on these drugs, this will be an impactful study.
The attached figure gives the summary.
The original article in this week’s New England Journal of Medicine is behind a paywall.”
Title: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
Authors: Lana A. Castellucci, Vivien M. Chen, Michael J. Kovacs, Alejandro Lazo-Langner, Peter Greenstreet, Susan Kahn, Benoit Côté, Sam Schulman, Kerstin de Wit, James Douketis, Deepa Suryanarayan, Tony Wan, Erik Yeo, Genevieve Le Templier, Huyen A. Tran, Abbey Willcox, Helen J. Crowther, Ritam Prasad, Sudeep Shivakumar, Etimbuk Umana, Fionnuala Ni Ainle, Tobias Tritschler, Stefano Barco, Jean-Philippe Galanaud, Marc Blondon, Lisa Baumann Kreuziger, Susan Solymoss, Clive Kearon, Erin Thomas, Tim Ramsay, Gregoire Le Gal, Marc Rodger
Read the Full Article on The New England Journal of Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 14, 2026, 12:03Grigoris Gerotziafas: Proud Moment for Team CaVITE at EHA 2026
-
Jun 14, 2026, 11:55VAYHIT3: Durable 12-Month Responses with Ianalumab in Primary ITP
-
Jun 14, 2026, 11:47Michael Makris: Proud to Present New Insights into Predicting Stroke Severity and Recovery at EHA 2026
-
Jun 14, 2026, 10:55Finn Guo: Driving a New Era of Accessible Gene Therapy for Hemophilia in China
-
Jun 14, 2026, 10:47Giulia Simini: Honored to Be Presenting My Award-Winning PhD Research at ISTH 2026
-
Jun 14, 2026, 10:42Sahil Gorka: A Step Forward in Optimizing Platelet Transfusion Assessment
-
Jun 14, 2026, 10:32Naveen Sharma: Fortis Hospital Shalimar Bagh Celebrates World Blood Donor Day with a Life-Saving Blood Donation Drive
-
Jun 14, 2026, 10:06François-Xavier Gros: A Memorable EHA 2026 Sets the Stage for Barcelona 2027
-
Jun 14, 2026, 09:26Jack Shuang Hou: Bezuclastinib Demonstrates Disease-Modifying Potential in Advanced Systemic Mastocytosis